Details of issuance or disposal
Issuance of share acquisition rights as stock options
Up to 800,000 shares (8,000 stock acquisition rights, each representing 100 shares)
The lower thin line represents the existing number of shares to which these shares will be added.
Approximately 0.6% (based on 127,971,881 issued shares as of the end of April 2026)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of share acquisition rights as stock options |
| Number of shares to be issued or disposed of | Up to 800,000 shares (8,000 stock acquisition rights, each representing 100 shares) |
| Issue price and disposal price | The stock acquisition rights will be issued at no cost. The exercise price will be determined based on an amount equal to 1.05 times the average closing price for the month preceding the month in which the allotment date falls. |
| Intended allottee | Category The Company's directors (excluding outside directors) and employees, directors and employees of the Company's subsidiaries, and outside collaborators / Number of Shares Up to 800,000 shares |
| Dilution Rate | Approximately 0.6% (based on 127,971,881 issued shares as of the end of April 2026) |
| Total number of issued shares | 127,971,881 shares → Not disclosed |
| Basis for determining the amount to be paid | An amount equal to 1.05 times the average closing price for regular trading on the Tokyo Stock Exchange on each trading day in the month preceding the month in which the allotment date falls. This represents a 5% premium to the average price. If the resulting amount is below the closing price on the allotment date, the closing price on the allotment date will apply. |
| Exercise price | Generally, 1.05 times the average closing price for the month preceding the month in which the allotment date falls; if this is below the closing price on the allotment date, the closing price on the allotment date will apply. Adjustment provisions apply in the event of a stock split, reverse stock split or similar event. The closing price on the allotment date will effectively serve as the floor. |
| Exercise period | For officers and employees of the Company or its subsidiaries: from the date falling 2 years after the date of issuance of the stock acquisition rights through the date falling 10 years after that date. For outside collaborators: from the date of issuance of the stock acquisition rights through the date falling 10 years after that date. |
| Number of Stock Acquisition Rights | The total number to be issued is capped at 8,000. The number of unexercised rights is Not disclosed. |
| Reason for acquisition without consideration | If a proposal for a merger or similar transaction in which the Company becomes the dissolving company is approved at a shareholders meeting, if a holder becomes unable to exercise the rights under the exercise conditions, or if a holder waives all or part of the rights. |
| Categories and Number of Persons Covered | The Company's directors (excluding outside directors) and employees, directors and employees of the Company's subsidiaries, and outside collaborators. The number of recipients and the number of shares allotted by category are Not disclosed. The number of stock acquisition rights allotted to the Company's directors is capped at 1,000 (100,000 shares). |
| Procedures under the Corporate Code of Conduct | Subject to approval of the proposal at the 22nd Annual General Meeting of Shareholders scheduled for 23 July 2026. |
| Impact on Business Performance | No specific impact on financial results has been disclosed at this time. |
Items this document does not state (14)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To provide medium- to long-term incentives to the officers and employees of the Company and its subsidiaries, and to grant stock acquisition rights to outside collaborators in line with the expected level of their contribution, thereby accelerating business development and global expansion across the Group and aiming to enhance corporate value and shareholder returns.